#commercialization - Techseriesinsight

August 4, 2025
PRNewswire
Artificial Intelligence, Cloud, News

EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology

EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today launched a groundbreaking pharmaceutical marketing AI agency running on an end-to-end AI-powered delivery platform built...

July 30, 2025
PRNewswire
Healthcare, News

Galaxy Therapeutics Opens New Manufacturing Facility to Support Global Commercialization

Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced the official opening of its new 9,200 square foot (855 m²) facility designed...

May 29, 2025
PRNewswire
Biotechnology

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson’s Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Ltd. (NYSE: BHVN) (“Biohaven”), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies to treat a broad range of rare and common diseases,...

May 28, 2025
PRNewswire
Healthcare

Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors

Biohaven Ltd. (NYSE: BHVN) (Biohaven), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today...

May 9, 2025
PRNewswire
Biotechnology

IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel

IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that its self-developed BCMA-targeted CAR-T cell...